Geopolitics Alpha

8-K - Unicycive Therapeutics, Inc. (0001766140) (Filer)

Published . Updated .

Key takeaways

  • 8-K - Unicycive Therapeutics filed an 8-K with the SEC on Nov 16 (a notice of a material company event).
  • Exposed: UNCY
  • Market reaction: UNCY +3.9% on the day (still updating)

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Get these market calls by email

The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.

Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.

GEOPOLITICS ALPHA8-K - Unicycive Therapeutics, Inc.(0001766140) (Filer)UNCYGEOPOLITICS ALPHA

8-K - Unicycive Therapeutics filed an 8-K with the SEC on Nov 16 (a notice of a material company event).

Directly affected

  • UNCY Unicycive Therapeutics

    Named in this report.

Indirectly affected

  • XLV Health Care Select Sector SPDR

    Health Care Select Sector SPDR holds the health sector that Unicycive Therapeutics belongs to, so it often moves with news about it.

  • LLY Eli Lilly and+25.1% 30d

    Eli Lilly and is a peer of Unicycive Therapeutics in pharmaceutical preparations; rivals often move on the same news.

  • JNJ Johnson & Johnson+12.1% 30d

    Johnson & Johnson is a peer of Unicycive Therapeutics in pharmaceutical preparations; rivals often move on the same news.

  • ABBV AbbVie+12.0% 30d

    AbbVie is a peer of Unicycive Therapeutics in pharmaceutical preparations; rivals often move on the same news.

  • MRK Merck+3.5% 30d

    Merck is a peer of Unicycive Therapeutics in pharmaceutical preparations; rivals often move on the same news.

  • ABT Abbott Laboratories+10.0% 30d

    Abbott Laboratories is a peer of Unicycive Therapeutics in pharmaceutical preparations; rivals often move on the same news.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
UNCY+3.94%+6.20%base+3.94%after closeafter closeafter close
XLV-0.28%+0.04%baseafter closeafter closeafter closeafter close
LLY-2.25%-0.49%baseafter closeafter closeafter closeafter close
JNJ-1.35%-1.97%baseafter closeafter closeafter closeafter close
ABBV-0.57%-0.04%base+1.51%after closeafter closeafter close
MRK+0.65%-0.38%baseafter closeafter closeafter closeafter close
ABT+1.85%+0.80%base+0.80%after closeafter closeafter close

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

Filed: 2026-11-16 AccNo: 0001213900-26-120261 Size: 246 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Source: sec-edgar

Price since this story was published: Unicycive Therapeutics (UNCY)

CompanyWhenMoveStatus
ABBVthat day+1.51%still updating
ABBVthree days earlier-0.04%final price
ABBVfive days earlier-0.57%final price
ABTthat day+0.80%still updating
ABTthree days earlier+0.80%final price
ABTfive days earlier+1.85%final price
JNJthree days earlier-1.97%final price
JNJfive days earlier-1.35%final price
LLYthree days earlier-0.49%final price
LLYfive days earlier-2.25%final price
MRKthree days earlier-0.38%final price
MRKfive days earlier+0.65%final price
Unicycive Therapeutics (UNCY)that day+3.94%still updating
Unicycive Therapeutics (UNCY)three days earlier+6.20%final price
Unicycive Therapeutics (UNCY)five days earlier+3.94%final price
XLVthree days earlier+0.04%final price
XLVfive days earlier-0.28%final price

Congressional trades in the stocks in this story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

Who is named in “8-K - Unicycive Therapeutics, Inc. (0001766140) (Filer)”

Companies tied to this story

  • UNCY Unicycive Therapeutics

    Unicycive Therapeutics (UNCY) is linked, with no stored direction, high confidence in the 16 Nov 2026 story “8-K - Unicycive Therapeutics, Inc. (0001766140) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> UNCY

How “8-K - Unicycive Therapeutics, Inc. (0001766140) (Filer)” reaches Unicycive Therapeutics (UNCY)

The 16 Nov 2026 story “8-K - Unicycive Therapeutics, Inc. (0001766140) (Filer)” names Unicycive Therapeutics (UNCY) because of this story.

For Unicycive Therapeutics (UNCY), the reason on file says SEC 8-K filing -> direct issuer disclosure -> UNCY

How strong the case is around Unicycive Therapeutics (UNCY)

14 out of 100Price not final

“8-K - Unicycive Therapeutics, Inc. (0001766140) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies. The price is not final yet.